2025 年 7 巻 p. 5-
To compare the difference and similarities in proteomic features between our established patient-derived sarcoma cell lines and their original tumor tissues, we conducted 18 LC-MS/MS runs for nine sarcoma patient-derived cell lines (PDCs) and their corresponding tumor tissues. The numbers of identified peptides and proteins were nearly identical between the two proteomic datasets in the sarcoma cell lines. Drug-targeted proteins in cancer-related genes were identified using these datasets.